Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection. Zhang D, Zhao Y, You X, He S, et al. Antimicrob Agents Chemother 2023;67:e0148722.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang D, Zhao Y, You X, He S, et al. Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother 2023;67:e0148722.
PMID: 36853000